- Amgen sheds around 40 staffers amid continuing strugglesAmgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.Fierce Biotech · 6h ago↗ source
- Sanofi halts development of troubled immune drug in eczema<figure><div><img src="https://imgproxy.divecdn.com/FBR1IQNmU9Hqatva496Zg2G8JMHsqV0UGsf4LMARqYo/g:nowe:189:144/c:1776:1003/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80OTY5MDc4Mzc…BioPharma Dive · 6h ago↗ source
- Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrappedSanofi had hoped the acquisition of Kymab would fill a major hole that will be left as autoimmune juggernaut Dupixent heads toward a patent cliff. Now, another therapy has failed to meet expectations.